ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Can Qrisk Be Useful to Predict Future Cardiovascular Co-Morbidites and Type II Diabetes in Living Kidney Donors Prior to Donation?

S. Bhutani, R. Chinnadurai, G. Bernal-Blanco, B. Patel, A. Summers, D. Van Dellen, M. Morton, P. Michael.

Department of Renal &
Transplant Medicine, Manchester Royal Infirmary, Manchester, United Kingdom.

Meeting: 2016 American Transplant Congress

Abstract number: C156

Keywords: Donation

Session Information

Date: Monday, June 13, 2016

Session Name: Poster Session C: Kidney Donor Evaluation and Donor Nephrectomy

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Incidence and Renal Consequences of Type 2 Diabetes Mellitus in Kidney Donors.
  • Measured Glomerular Filtration Rate of the Remaining Kidney Divided by Its Volume Prior to Donation Is a Predictor of the Long-Term Gain of Function in Living Kidney Donors.

Introduction:

Living kidney donor transplantation has demonstrated significant survival benefits to individuals with End Stage Renal Disease (ESRD). However, The long term cardiovascular risks associated with kidney donation are unclear.

Methods:

Retrospective data was collected on Kidney donors (n=128) who underwent pre-Kidney donation assessment followed by Donor nephrectomy at our centre ( January 2009 to August 2014). Both QDiabetes® diabetes and QRISK®2-2015 Web Calculator were used to calculate 10 year risk of developing Type 2 diabetes and cardiovascular event prior to donation.

Results:

Among the cohort of 128 patients (m= 66, f=62), mean age of donors was 45 ± 10 years. Majority of the donors (62%) were from 5th to 6th decade {n=40 (20-39 yrs), n= 43(40-49 yrs), n=37(50-59 yrs), n=16(60-79 yrs.)}. 42 % of the patients were overweight (BMI 25-30 Kg/m2) and 17 % were obese (BMI >30Kg/m2).

Mean Body Mass Index and cholesterol/HDL ratio were 27.34 ± 3.52, 4.08±1.49 in males and 25.80±3.6, 3.43±0.97 in females respectively. The mean Qrisk in men was 6.95% and 5.5% in women. 12.5% of donors had a Qrisk score of > 10% which is considered to be a trigger for intervention. These donors had a trend towards higher number of cardiovascular co-morbidities during follow up (hypertension, hypercholesterolemia) (p = 0.06). The QRISK figures were however lower than in the general population, which averages 8.66% in men and 6.57% in women. The mean Q risk scores for diabetes were 5.05% for men and 3.55% for women. This was again lower than the averages for the general population which are 6.12% (6.05-6.19) for men and 4.72% (4.66-4.78) for women.

Discussion:

This study has demonstrated that QRISK for cardiovascular disease in living kidney transplant donors is generally lower than in the normal population. Donors with a QRISK of > 10% had more cardiovascular comorbidities recorded in follow up although no cardiovascular events were reported during this time frame. The QRISK for Diabetes was also lower than the general population. In conclusion calculation of the QRISK scores for diabetes and cardiovascular comorbidities may be useful in predicting the long term complications following living kidney donation. Donors with QRISK >10% should be considered for prophylactic interventions to reduce post donation cardiovascular risk.

CITATION INFORMATION: Bhutani S, Chinnadurai R, Bernal-Blanco G, Patel B, Summers A, Van Dellen D, Morton M, Michael P. Can Qrisk Be Useful to Predict Future Cardiovascular Co-Morbidites and Type II Diabetes in Living Kidney Donors Prior to Donation? Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Bhutani S, Chinnadurai R, Bernal-Blanco G, Patel B, Summers A, Dellen DVan, Morton M, Michael P. Can Qrisk Be Useful to Predict Future Cardiovascular Co-Morbidites and Type II Diabetes in Living Kidney Donors Prior to Donation? [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/can-qrisk-be-useful-to-predict-future-cardiovascular-co-morbidites-and-type-ii-diabetes-in-living-kidney-donors-prior-to-donation/. Accessed February 28, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.